AreteiaTx
Christopher Courts, CPA has significant experience in finance as a Chief Financial Officer (CFO) and VP of Finance. Christopher most recently served as the CFO at AreteiaTx since October 2022. Prior to that, they were the CFO at Pebble Labs Inc. from October 2019 to October 2022. From an earlier period, starting in 2016 until October 2019, Christopher was the CFO at Vitrisa Therapeutics. Christopher also held the position of CFO and VP of Finance at Regado BioSciences, Inc. from 2006 to 2015.
Christopher Courts, CPA has a BA and MBA degree in Finance from Marshall University. In addition to their educational background, they have also obtained a certification as a Certified Public Accountant from an undisclosed institution. The specific month and year of obtaining this certification are not provided.
This person is not in any offices
AreteiaTx
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments.